DUBLIN--(BUSINESS WIRE)--The "Global Nuclear Medicine Market Analysis & Trends - Industry Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
Report Highlights
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2027, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2027
- Market opportunities and recommendations for new investments
Key Topics Covered
1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Product Analysis
1.5 Application Analysis
1.6 Strategic Benchmarking
1.7 Opportunity Analysis
2 Executive Summary
3 Market Overview
3.1 Current Trends
3.1.1 Increasing Incidents of Cancer and Cardiac Ailments
3.1.2 Increasing Spect Radiopharmaceuticals and Pet Radiopharmaceuticals Applications
3.1.3 Growing Public Awareness for Healthcare
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry
4 Nuclear Medicine Market, By Product
4.1 Therapeutic Products
4.1.1 Brachytherapy
4.1.1.1 Palladium - 103
4.1.1.2 Iridium - 192
4.1.1.3 Iodine - 125
4.1.1.4 Cesium - 131
4.1.1.5 Other Brachytherapy Products
4.1.2 Alpha Emitters
4.1.2.1 RA - 223
4.1.2.2 Other Alpha Emitters
4.1.3 Beta Emitters
4.1.3.1 SM - 153
4.1.3.2 Y - 90
4.1.3.3 Lu - 117
4.1.3.4 Re - 186
4.1.3.5 I - 131
4.1.3.6 Other Beta Emitters
4.2 Diagnostic Products
4.2.1 PET Radiopharmaceuticals
4.2.1.1 SR - 82/RB - 82
4.2.1.2 F -18
4.2.1.3 Other PET Products
4.2.2 SPECT Radiopharmaceuticals
4.2.2.1 TL - 201
4.2.2.2 I - 123
4.2.2.3 TC - 99m
4.2.2.4 GA - 67
4.2.2.5 Other SPECT Products
5 Nuclear Medicine Market, By Procedures
5.1 Central Nervous System
5.2 Gastrointestinal
5.3 Pulmonary
5.4 Therapeutic
5.5 Cardiovascular
5.6 Endocrine
5.7 Genito-Urinary
5.8 PET & PET-CT
5.9 Skeletal
5.10 Other Procedures
6 Nuclear Medicine Market, By Application
6.1 Therapeutic Application
6.1.1 Lymphoma
6.1.2 Thyroid
6.1.3 Endocrine Tumor
6.1.4 Bone Metastasis
6.1.5 Other Therapeutic Application
6.2 Diagnostic Application
6.2.1 Oncology
6.2.2 Cardiology
6.2.3 Neurology
6.2.4 Other Diagnostic Application
7 Nuclear Medicine Market, By Geography
7.1 North America
7.2 Europe
7.3 Asia Pacific
7.4 Middle East
7.5 Latin America
7.6 Rest of the World (RoW)
8 Key Player Activities
8.1 Acquisitions & Mergers
8.2 Agreements, Partnerships, Collaborations and Joint Ventures
8.3 Product Launch & Expansions
8.4 Other Activities
9 Leading Companies
9.1 GE Healthcare
9.2 Siemens Healthcare
9.3 NTP Radioisotopes
9.4 Cardinal Health, Inc.
9.5 Lantheus Holdings
9.6 Triad Isotopes
9.7 Fujifilm Holdings Corporation
9.8 Sigma-Aldrich Corporation.
9.9 Cambridge Isotope Laboratories, Inc.
9.10 Nordion, Inc.
9.11 IBA Group
9.12 Eczacibasi-Monrol
9.13 Bracco S.p.A.
9.14 Medtronic
9.15 Jubilant Pharma LLC
For more information about this report visit https://www.researchandmarkets.com/research/clmcjz/global_nuclear?w=4